twenty-seven patients with squamous cell carcinoma of the head and neck were treated with bleomycin 7.5 u/m2/day continuous infusion x 3 days ( days 1-4 , 8-11 ) , followed by cyclophosphamide 300 mg/m2 , methotrexate 30 mg/m2 and 5-fluorouracil 300 mg/m2 on days 5 and 12 ( bleo-cmf ) .
C0025677
methotrexate
C0950521
cmf